Cargando…

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19

Detalles Bibliográficos
Autores principales:	Principi, Nicola, Esposito, Susanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164862/ https://www.ncbi.nlm.nih.gov/pubmed/32311322 http://dx.doi.org/10.1016/S1473-3099(20)30296-6

Ejemplares similares

Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
por: Carafoli, Ernesto
Publicado: (2021)

Hydroxychloroquine prophylaxis for COVID-19 contacts in India
por: Rathi, Sahaj, et al.
Publicado: (2020)

Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19: What Is Known?
por: Shankar, Pathiyil Ravi, et al.
Publicado: (2021)

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
por: Pareek, Anil, et al.
Publicado: (2020)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach
por: Tilangi, Praveen, et al.
Publicado: (2020)

Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
por: Kaur, Hardeep, et al.
Publicado: (2021)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
por: Singh, Bhagteshwar, et al.
Publicado: (2021)

Evidence for Chloroquine/Hydroxychloroquine in the Treatment of COVID-19
por: Shetty, Rajesh M, et al.
Publicado: (2021)

Side effects of hydroxychloroquine prophylaxis against COVID-19 in healthcare workers
por: Dixit, Prashant Kumar, et al.
Publicado: (2021)

Chloroquine/hydroxychloroquine overdose
por: McKeever, Rita
Publicado: (2020)

Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014)

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
por: Liu, Jia, et al.
Publicado: (2020)

Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?
por: Kamp, Timothy J., et al.
Publicado: (2020)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
por: Colson, Philippe, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine increase risk of death in COVID-19
Publicado: (2020)

Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
por: Gupta, Anunay, et al.
Publicado: (2020)

Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
por: Bahadoram, Mohammad, et al.
Publicado: (2021)

Interpreting the impact of hydroxychloroquine prophylaxis on SARS-CoV-2 infection
por: Yadav, Reetika Malik, et al.
Publicado: (2021)

Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers
por: Karim, Habib M.R., et al.
Publicado: (2020)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
por: Stevens, David M., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine for cancer therapy
por: Manic, Gwenola, et al.
Publicado: (2014)

Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021)

Janus sword actions of chloroquine and hydroxychloroquine against COVID-19
por: Chen, Xuesong, et al.
Publicado: (2020)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
por: Babayeva, Mariana, et al.
Publicado: (2020)

Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19
por: Zou, Li, et al.
Publicado: (2020)

Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
por: Ibáñez, Sebastián, et al.
Publicado: (2020)

Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19
por: Ruamviboonsuk, Paisan, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19
por: Lei, Zi-Ning, et al.
Publicado: (2020)

RETRACTED: Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
por: Gasmi, Amin, et al.
Publicado: (2021)

Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery
por: Chen, Yao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7tplaf34qkbck4cn689s89u30b